Skip to main content
Premium Trial:

Request an Annual Quote

Avacta Raises $17M, Inks UbiQ Bio Collaboration to Support Affimer Development


NEW YORK (GenomeWeb) – Biotech firm Avacta Group said this week that it has raised £10.1 million ($17 million) from a placing of 918,181,820 new ordinary shares with institutional shareholders at a price of 1.1 pence per share.

Additionally, the company has granted an option to underwriter Numis Securities that requires it to issue up to an additional 218,181,818 new shares to meet additional demand should Numis accept additional requests to purchase shares.

Avacta said that it plans to use the net proceeds – totaling approximately £9.7 million if no option shares are issued, or up to £12.1 if the maximum number of option shares are issued – to accelerate development and commercialization of its affimer affinity reagents, non-antibody reagents based on the protein stefin A that can be engineered to bind to a wide range of protein targets.

The company also announced this week a collaboration with UbiQ Bio, a supplier of ubiquitylated peptides and related assays, under which UbiQ Bio will provide Avacta with ubiquitylated peptides for screening against its affimer library. UbiQ will receive a royalty on sale of any ubiquitylation affirmers generated through the collaboration.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.